Copper arsenite-complexed Fenton-like nanoparticles as oxidative stress-amplifying anticancer agents
Tài liệu tham khảo
Perillo, 2020, ROS in cancer therapy: the bright side of the moon, Exp. Mol. Med., 52, 192, 10.1038/s12276-020-0384-2
Fruehauf, 2007, Reactive oxygen species: a breath of life or death?, Clin. Cancer Res., 13, 789, 10.1158/1078-0432.CCR-06-2082
Schumacker, 2006, Reactive oxygen species in cancer cells: live by the sword, die by the sword, Cancer Cell, 10, 175, 10.1016/j.ccr.2006.08.015
Raj, 2011, Selective killing of cancer cells by a small molecule targeting the stress response to ROS, Nature, 475, 231, 10.1038/nature10167
Alexandre, 2006, Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo, Int. J. Cancer, 119, 41, 10.1002/ijc.21685
Hu, 2020, Modulating intracellular oxidative stress via engineered nanotherapeutics, J. Control. Release, 319, 333, 10.1016/j.jconrel.2019.12.040
Maeda, 2004, Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine, Cell Death Differ., 11, 737, 10.1038/sj.cdd.4401389
Noh, 2015, Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death, Nat. Commun., 6, 6907, 10.1038/ncomms7907
Chen, 2021, Recent advances of redox-responsive nanoplatforms for tumor theranostics, J. Control. Release, 332, 269, 10.1016/j.jconrel.2021.02.030
Živojević, 2021, Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications, J. Control. Release, 337, 193, 10.1016/j.jconrel.2021.07.029
Wang, 2021, Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy, J. Control. Release, 333, 500, 10.1016/j.jconrel.2021.04.007
Ranji-Burachaloo, 2018, Cancer treatment through nanoparticle-facilitated Fenton reaction, ACS Nano, 12, 11819, 10.1021/acsnano.8b07635
Yang, 2021, Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy, J. Control. Release, 334, 21, 10.1016/j.jconrel.2021.04.013
Shen, 2018, Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors, ACS Nano, 12, 11355, 10.1021/acsnano.8b06201
Dong, 2019, Amplification of tumor oxidative stresses with liposomal Fenton catalyst and glutathione inhibitor for enhanced cancer chemotherapy and radiotherapy, Nano Lett., 19, 805, 10.1021/acs.nanolett.8b03905
Liu, 2019, One-dimensional Fe2P acts as a Fenton agent in response to NIR II light and ultrasound for deep tumor synergetic theranostics, Angew. Chem. Int. Ed., 58, 2407, 10.1002/anie.201813702
Ma, 2019, Self-assembled copper–amino acid nanoparticles for in situ glutathione “AND” H2O2 sequentially triggered chemodynamic therapy, J. Am. Chem. Soc., 141, 849, 10.1021/jacs.8b08714
Zhang, 2013, Anti-bacterial and in vivo tumor treatment by reactive oxygen species generated by magnetic nanoparticles, J. Mater. Chem. B, 1, 5100, 10.1039/c3tb20907e
Fu, 2015, Lysosome-controlled efficient ROS overproduction against cancer cells with a high pH-responsive catalytic nanosystem, Nanoscale, 7, 7275, 10.1039/C5NR00706B
Zhang, 2016, Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction, Angew. Chem. Int. Ed., 55, 2101, 10.1002/anie.201510031
Akhtar, 2017, Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers, J. Biomed. Res., 31, 177, 10.7555/JBR.31.20160059
Wu, 2020, Delivery of arsenic trioxide by multifunction nanoparticles to improve the treatment of hepatocellular carcinoma, ACS Appl. Mater. Interfaces, 12, 8016, 10.1021/acsami.9b22802
Ahn, 2010, A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer, Clin. Cancer Res., 16, 3607, 10.1158/1078-0432.CCR-10-0068
Fei, 2009, Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization, Med. Oncol., 26, 178, 10.1007/s12032-008-9105-8
Liu, 2009, Possible roles of a tumor suppressor gene PIG11 in hepatocarcinogenesis and As2O3-induced apoptosis in liver cancer cells, J. Gastroenterol., 44, 460, 10.1007/s00535-009-0030-1
Chen, 1998, Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis, J. Cell. Physiol., 177, 324, 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9
Miller, 2002, Mechanisms of action of arsenic trioxide, Cancer Res., 62, 3893
Min, 2015, pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers, ACS Nano, 9, 134, 10.1021/nn506210a
Nam, 2017, Mussel-inspired poly(L-DOPA)-templated mineralization for calcium phosphate-assembled intracellular nanocarriers, Colloids Surf. B: Biointerfaces, 157, 215, 10.1016/j.colsurfb.2017.05.077
Deng, 2012, Enzymatically triggered multifunctional delivery system based on hyaluronic acid micelles, RSC Adv., 2, 12909, 10.1039/c2ra21888g
Harada, 1998, Novel polyion complex micelles entrapping enzyme molecules in the core: preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium, Macromolecules, 31, 288, 10.1021/ma971277v
Zhao, 2012, Electro-Fenton oxidation of pesticides with a novel Fe3O4@Fe2O3/activated carbon aerogel cathode: high activity, wide pH range and catalytic mechanism, Appl. Catal. B, 125, 120, 10.1016/j.apcatb.2012.05.044
Masomboon, 2009, Chemical oxidation of 2,6-dimethylaniline in the Fenton process, Environ. Sci. Technol., 43, 8629, 10.1021/es802274h
Bokare, 2014, Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes, J. Hazard. Mater., 275, 121, 10.1016/j.jhazmat.2014.04.054
Cao, 2020, A simultaneously GSH-depleted bimetallic cu (II) complex for enhanced chemodynamic cancer therapy, Dalton Trans., 49, 11851, 10.1039/D0DT01742F
Brillas, 2004, Catalytic effect of Fe2+, Cu2+ and UVA light on the electrochemical degradation of nitrobenzene using an oxygen-diffusion cathode, New J. Chem., 28, 314, 10.1039/B312445B
Soltani, 2017, Enhanced formation of sulfate radicals by metal-doped BiFeO3 under visible light for improving photo-Fenton catalytic degradation of 2-chlorophenol, Chem. Eng. J., 313, 1258, 10.1016/j.cej.2016.11.016
Hwang, 2014, pH-responsive robust polymer micelles with metal-ligand coordinated core cross-links, Chem. Commun., 50, 4351, 10.1039/c4cc01584c
Sever, 2004, Visible absorption spectra of metal-catecholate and metal-tironate complexes, Dalton Trans., 1061-1072
Boggess, 1975, Copper (II) chelation by dopa, epinephrine, and other catechols, J. Am. Chem. Soc., 97, 3076, 10.1021/ja00844a026
Chen, 2006, Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release, J. Am. Chem. Soc., 128, 13348, 10.1021/ja064864h
Zhao, 2015, Real-time monitoring of arsenic trioxide release and delivery by activatable T1 imaging, ACS Nano, 9, 2749, 10.1021/nn506640h
Lee, 2011, Triggered release of pharmacophores from [Ni(HAsO3)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: a combined experimental and theoretical study, ACS Nano, 5, 3961, 10.1021/nn200478m
Suk, 2016, PEGylation as a strategy for improving nanoparticle-based drug and gene delivery, Adv. Drug Deliv. Rev., 99, 2851
Opanasopit, 2005, Influence of serum and albumins from different species on stability of camptothecin-loaded micelles, J. Control. Release, 104, 313, 10.1016/j.jconrel.2005.02.014
Zhao, 2012, Enhanced stability of polymeric micelles based on postfunctionalized poly(ethylene glycol)-b-poly(γ-propargyl l-glutamate): the substituent effect, Biomacromolecules, 13, 1315, 10.1021/bm201873u
Garg, 2015, Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): an in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity, Colloids Surf. B: Biointerfaces, 132, 161, 10.1016/j.colsurfb.2015.05.015
Aguiar, 2007, Mechanism and applications of the Fenton reaction assisted by iron-reducing phenolic compounds, Quim Nova, 30, 623, 10.1590/S0100-40422007000300023
Oikawa, 2001, Site specificity and mechanism of oxidative DNA damage induced by carcinogenic catechol, Carcinogenesis, 22, 1239, 10.1093/carcin/22.8.1239
Baila, 1992, Copper (II)-catalyzed oxidation of catechol by molecular oxygen in aqueous solution, Inorg. Chem., 31, 58, 10.1021/ic00027a012
Rehmani, 2017, Copper-mediated DNA damage by the neurotransmitter dopamine and L-DOPA: a pro-oxidant mechanism, Toxicol. in Vitro, 40, 336, 10.1016/j.tiv.2017.01.020
Mizutani, 2019, Oxidative DNA damage and apoptosis induced by aclarubicin, an anthracycline: role of hydrogen peroxide and copper, Anticancer Res., 39, 3443, 10.21873/anticanres.13490
Hou, 2021, Unsaturated fatty acid-tuned assembly of photosensitizers for enhanced photodynamic therapy via lipid peroxidation, J. Control. Release, 334, 213, 10.1016/j.jconrel.2021.04.022
Xia, 2021, Synthetic infrared nano-photosensitizers with hierarchical zoom-in target-delivery functionalities for precision photodynamic therapy, J. Control. Release, 334, 263, 10.1016/j.jconrel.2021.04.031
Kalyanaraman, 2012, Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations, Free Radic. Biol. Med., 52, 1, 10.1016/j.freeradbiomed.2011.09.030
Sun, 2014, Graphene quantum dots-band-aids used for wound disinfection, ACS Nano, 8, 6202, 10.1021/nn501640q
Kwon, 2016, Nano-Fenton reactors as a new class of oxidative stress amplifying anticancer therapeutic agents, ACS Appl. Mater. Interfaces, 8, 5887, 10.1021/acsami.5b12523
Maeda, 2015, Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity, Adv. Drug Deliv. Rev., 91, 3, 10.1016/j.addr.2015.01.002
Fang, 2020, Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers, Adv. Drug Deliv. Rev., 157, 142, 10.1016/j.addr.2020.06.005